ABSTRACT: MMP-2 and MMP-9 are proteins with well stablished roles on the remodeling of tissue during morphogenesis. This study aimed to evaluate the activity and expression of the MMP-2 and MMP-9 in the rat small intestine mucosa layer on 15 th and 18 th days of intratuterine life (i.u.) and at 3rd, 10 th , 17 th, 25 th , and 32 th days after birth (a.b.). Samples were submitted to zimography, immunohistochemistry methods and Masson trichrome staining. Results showed that MMP-2 and MMP-9 were not expressed in the small intestine epithelium during intrauterine life.
INTRODUCTION
In the mammalian, small and large intestines begin their development from the lateral fusion of the endoderm (Noah et al, 2011) during the intrauterine (i.u.) life. In rats, the primordial digestory tube formed is lined by undifferentiated epithelial cells arranged in multilayers that are maintained until approximately the 13th day of i.u. life (Smith et al., 2000; Louvard et al., 1992) , where the small intestine differentiation processes begins. Around the 19th day (i.u.) it is already possible to detect villi structures emerging from the epithelium surface. After birth, rat pass through suckling and weaning phases, in which several changes occur in the intestinal epithelium to ensure the differentiation of the various cell types such as endocrine and goblet cells as well as the closure of the absortive process.
which demonstrated the same pattern of the results for each sample (data not showed). Then we decided to produce a pool of the samples by time evaluated. For zymography, the following procedures were perfomed: from each pool, 0,1 µg of total protein were diluted in non-reduced Laemmli buffer and were submitted to electrophoresis in a 10% polyacrylamide gel containing 5% gelatin, for 4 h. Gels were rinsed twice (30min) in 2.5% Triton X-100, under shaking, and then immersed in activation buffer (2M CaCl2; 1M HCl) for 16 h at 37°C. Gels were stained with Coomassie Blue until the degraded bands could be seen. Other gels were submitted to inhibition tests using 1,10-fenantrolina e EDTA 5mM (MMP inhibitors); iodoacetamide 1mM (cisteine inhibidor ) and phenylmethylsulfonyl fluoride 2mM (PMSF-serine inhibitor). The inhibitors were purchade from SIGMA: PMSF cod. 329-98-6; EDTA cod. 60-00-4; PHE cod 66-71-7;
Iodoacetamide cod 144-48-9
Histological procedures: For each of the intrauterine times, a cross section in each embryo was performed at the thoracic level and the abdominal part. Sections were immersed in 2% formaldehyde prepared in 0.1M phosphate buffer, pH 7.4, for 48 hours. After birth, the jejunum fragments were submitted to the same fixative solution for the same time. Afterwards, samples were dehydrated in alcohol, rinsed in xylol and embedded in paraffin to obtain three semi-seriated sections of 5µm. The sections were mounted on slides for immunohistochemical procedures.
Immunohistochemistry for MMP-9 and MMP-2
For this analysis, three slides containg three embryon, and three fragment of small intestine (obtained after birth) were dewaxing and submitted to antingenic recovery in EDTA 1mM pH 8.0 at 98ºC for 20 min. After that, sections were quenched three times with 2% hydrogen peroxide for 10 min each to inhibit endogenous peroxidase activity. Sections were washed in water and PBS pH 7.4 and immunostained with primary antibodies (2ug/ml, purchased from Millipore USA) as follows: MMP-9 (1:250 cod MAB3309 and MMP-2 (1:250-cod MAB3308) in PBS containing 1% BSA, and incubated overnight. Sections were then washed in PBS and incubated with secondary antibody using DAKO (Universal LSAB kit Cod K067511-2 ) for 30 min at 37C in each solution. After washing in PBS, sections were incubated with the DAB reagent (SIGMA -cod D3939) prepared in PBS in the presence of hydrogen peroxide. Negative control staining was performed for each molecule by either omitting the primary antiserum or substituting the primary antiserum with nonimmune serum.
RESULTS

MMP-9 and MMP-2 were not expressed during the development of small intestine in the intrauterine life.
According to zymograms results, demonstrated in the figure 1 A, there is no proteolytic activity for gelatin degradation at 15th and 18th days of the intrauterine life. These results were confirmed by the immunohistochemistry presented in Figure 2 A, B, C, and D for the times evaluated, in which the MMP-2 and MMP-9 were not detected.
During the postnatal development of the small intestine only MMP-9 is expressed
Concerning to zymogram results obtained for the 3th and 10th days, (suckling period), 17th (preweaning period) and 25 and 32th days (weaning period) demonstrated in the Fig. 1A , it was possible to detect a 90 kDA protein with a proteolytic activity, which corresponds to the molecular weight to MMP-9. Another protein with a proteolytic activity was detected at 72 kDA however, only for samples obtained on the 32nd day.
However, after the use of the phenantroline plus EDTA (Fig 1B ) as well as the PMSF (Fig. 1C) which are MMP and Serinase inhibitors, respectively, the results show an inhibitory effect on the proteolytic activity at 90 kDA and 72 kDA levels in all times evaluated. However, the iodocetamina, which is a Cisteinase inhibitor (Figure 1 D) , was not able to inhibit proteolytic activity in small intestine samples in any time evaluated.
In the immunohistochemistry the MMP-2 was not detected on the 3rd, 10th, 17th, 25th and 32th days as shown in the Figure 3 from A to E. However, MMP-9 was immunolocalized in the goblet cells cytoplasm, in the villus (arrow -Fig 3 F') , on 3rd and 10th days but not in the next times 
DISCUSSION
The small intestine is a vital organ for the homeostasis of body systems because all essential nutrients for the cell metabolism are intaken at small intestine level. In addition, small intestine also acts as a barrier between the body internal and external environment (De Mey and Freund, 2013) .
However, during all phases of development, the small intestine is under influence of the external factors, mainly light and the food (Soares et al., 2009) . In mammalian, the first food intake after birth is milk. This phase is defined as suckling which in rats ends around the 17nd day a.b. After this time, the animal goes to the weaning phase when the food habit becomes diversified, indicating that during the small intestine development there are several adaptations concerning its morphophysiological functions, especially in enzymes expression.
It is known that MMP-2 and MMP-9 are involved in the remodeling and signalization process of the extracellular matrix such as the modulation of the biological growth factors and cell proliferation in normal tissue developmental repair or during the progression of several degenerative diseases (Stamenkovic 2003 , Phillips et al., 2017 , Nawaz et al., 2018 However, after birth although a gelatin band degradation corresponding to the MMP-2 was present in the zymogram on the 32nd day, it was not detected by immunohistochemistry in any of phases evaluated (suckling, pre-weaning, and weaning). This results suggest that on the 32nd day that gelatin band degradation may be not MMP-2. Taken together, the results from the postnatal and the intrauterine life indicates that MMP-2 is not present in any phase of development of small intestine, and in addition to that described by Camargo et.al., (2016) , it alowed us to suggest that the MT1-MMP may have the main role during the remodeling of the epithelial layer of the small intestine.
The MMP-9 expression was detected in the zymogram at all times evaluated and also by immunohistochemistry method in the goblet cells (in some times evaluated) and in the cells localized in the lamina propria but not in the epithelial cells, as we had hypothesized.. However, the use of the MMP and Serinases inhibitors reduced the proteolytic activity at 90 kDA. Additional results showed that, in the lamina propria, mast cells were expressing MMP-9. This cell was distributed in the center of the villus, between the epithelial cells and around of mucosal glands from the 17th day after birth. The presence of MMP-9 in the mast cells and the zymograms and inhibitory test are consistent because the literature shows that the mast cells produces several pharmacological molecules including the Chymase and Tryptase (two serinases), which are major proteins present in the granules of the mast cells (Katunuma & Kido, 1988; Lees et. al, 1994) .
Chymase and tryptase also act in the degradation of the extracellular matrix components. Chymase of mast cells is also involved in the permeability of the epithelial cells changing the distribution of the tight junction proteins (Scudamore et. al., 1988) . Therefore, the results for the inhibitory test using the PHE and PMSF showed a reduction in the band degradation for both inhibitors which suggest that the band present in the PHE test is the serinase and the band present in the PMSF test is MMP-9. This is a plausible and interesting interpretation obtained in this investigation, once that the mast cells may express both MMPs and Serinases.
In addition, the presence of mast cells in the gastrointestinal wall may be implicated in several biological functions, such as allergic reactions to food, smooth muscle contraction and peristalsis, induction of acid secretion, electrolytes and mucines by the epithelial cells, and host defense against microbes like bacteria, viruses, or parasites (Bischoff, 2009) . The role of mast cells and its pharmacological molecules on the inflammatory modulation as well as in the adaptative and especially in the innate immunity has been also discussed (Pejler et al., 2010; Douaiher et al 2014; Cardamone et al., 2016; Pastwińska et al 2017; Xu et al., 2018) . The activation of the pro-MMP-9 was demonstrated in vitro in the presence of the mouse mast cell protease-4 (mMCP-4) obtained from bone marrow-derived cultured (Tchougounova et. al., 2005; Lin et al., 2011) .
In spite of the knowledge existing about the mast cell and its presence in several organs including small intestine, until the current moment we could not find any report about the relationship between the mast cells and the phases of the small intestine development (suckling, pre-weaning and weaning). Because that mast cells expressing MMP-9 were detected from the 10th day after birth, we suggest that it may be involved, for example, in the remodeling of extracellular matrix in case of the inflammatory process, as observed in the others immunological cells such as macrophage (Butoi et., al 2016) however, this still needs to be confirmed during the small intestine development in further investigations.
In conclusion, our results showed that MMP-2 and MMP-9 were not expressed in the epithelial cells during the intrauterine and post natal development of the small intestine however, MMP-9 was expressed in the mast cell present in the lamina propria after birth indicating its involvement in the development of the small intestine innate immunity. 
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